Answers are grounded in this paper and cite their sources.
Commentary highlights lipid monitoring needs in patients on enzyme-inducing antiseizure medications, suggesting psychotropic co-prescriptions alter cardiovascular risk.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: